Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin
Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study

Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study

The Deep and Frequent Phenotyping Study (DFP) is a multi-centre, observational study of prodromal Alzheimer’s disease (AD) and forms part of the Dementias Platform UK. The study includes a wide range of established and novel biomarkers and aims to identify a set of multi-modal markers for phenotyping prodromal AD, as part of the study, CANTAB cognitive tests are being used at multiple time points to assess changes in cognitive function. Prior to study initiation, a pilot study was conducted as a proof of concept to assess task suitability and participant acceptability of extensive and repeated phenotyping and the acceptability of the CANTAB tasks was also assessed in this feasibility study.

Download the poster presented at the Dementias Platform UK scientific meeting 2017. 

Download form

Please complete all fields marked*

download

Country *

Area of interest *


We would like to keep you informed with the latest news, data and innovations from the neuroscience and clinical trial community. We'll always treat your contact information with great care and will never allow other companies to access your information for marketing purposes.

Please let us know if you would like us to contact you or not by selecting one of the options below.

 

Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study
Share this